The aim of this study is to retrospectively evaluate the indocyanine green (ICG) angiographic features in 13 patients affected by multifocal choroiditis. We identified two clinical and angiographic patterns. The ‘active’ pattern showed hypofluorescence up to the late phases and more extensive choroidal involvement than presumed by ophthalmoscopy and fluorescein angiography. In the ‘inactive’ pattern, ICG angiography showed hypofluorescence during all the phases: no increase in lesion number was observed between early and late phases. Choroidal neovascularization was present in 10 patients, and it was bilateral in 2 of these: it occurred only in the inactive stage. The appearance of choroidal lesions in IGC angiography supports the hypothesis of inflammatory involvement of the choriocapillaris as the pathophysiological mechanism of the disease.

Keywords:
Multifocal choroiditis, Indocyanine green angiography, Ocular inflammation
1.
Nozic RA, Dorsch W: A new chorioretinopathy associated with anterior uveitis. Am J Ophthalmol 1973;76:758–765.
2.
Doran RML, Hamilton AM: Disciform macular degeneration in young adults. Trans Ophthalmol Soc UK 1982;102:471–477.
3.
Watzke RC, Packer AJ, Folk JC, Benson WE, Burgess D, Ober RR: Punctate inner choroidopathy. Am J Ophthalmol 1984;98:572–584.
4.
Palestine AG, Nussenblatt RB, Parver LM, Knox DL: Progressive sub-retinal fibrosis and uveitis. Br J Ophthalmol 1984;66:667–673.
5.
Dreyer RF, Gass JMD: Multifocal choroiditis and panuveitis: A syndrome that mimics ocular histoplasmosis. Arch Ophthalmol 1984;102:1776–1784.
6.
Deutsch TA, Tessier HH: Inflammatory pseudohistoplasmosis. Ann Ophthalmol 1985;17:461–467.
7.
Cantrill HL, Folk JC: Multifocal choroiditis associated with progressive sub-retinal fibrosis. Am J Ophthalmol 1986;101:170–180.
8.
Morgan CM, Schatz H: Recurrent multifocal choroiditis. Ophthalmology 1986;93:1138–1146.
9.
Guyer DR, Puliafito CA, Mones JM, Friedman E, Chang W, Verdooner SR: Digital indocyanine-green angiography in chorio-retinal disorders. Ophthalmology 1992;99:287–291.
10.
Yannuzzi LA, Slakter JS, Sorenson JA, Guyer DR, Orlock DA: Digital indocyanine green videoangiography and choroidal neovascularization. Retina 1992;12:191–223.
11.
Dhaliwal RS, Maguire AM, Flower RW, Arribas NP: Acute posterior multifocal placoid pigment epitheliopathy: An indocyanine green angiographic study. Retina 1993;13:317–325.
12.
Ie D, Glaser BM, Murphy RP, Gordon LW, Sjaarda RN, Thompson JT: Indocyanine green angiography in multiple evanescent white-dot syndrome. Am J Ophthalmol 1994;117:7–12.
13.
Gass JDM: Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol 1968;80:177–185.
14.
Gass JDM: Stereoscopic Atlas of Macular Disease, ed 3. St Louis, Mosby, 1987, pp 504–509.
15.
Park D, Schatz H, McDonald R, Johnson RN: Indocyanine green angiography of acute multifocal posterior placoid pigment epitheliopathy. Ophthalmology 1995;102:1877–1883.
16.
Slakter JS, Giovannini A, Yannuzzi LA, Scassellati-Sfarzolini B, Guyer DR, Sorenson JA, Spaide RF, Orlock D: Indocyanine green videoangiography of multifocal choroiditis. Ophthalmology 1997;104:1813–1819.
17.
Palestine AG, Nussenblatt RB, Chan C: Histopathology of the sub-retinal fibrosis and uveitis syndrome. Ophthalmology 1985;92:838–845.
18.
Gass JDM: Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63:678–687.
19.
Ryan SJ: Histopathological correlates of presumed ocular histoplasmosis. Int Ophthalmol Clin 1975;15:125–131.
20.
Connor T, Glaser BM: RPE cells can simultaneously release inhibitors and stimulators of endothelial cell proliferation. Invest Ophthalmol Vis Sci 1987;28(suppl):203–207.
21.
Glaser BM, Campochiaro PA, Davis JL, Jerdan JA: Retinal pigment epithelial cells release inhibitors of neovascularization. Ophthalmology 1987;94:780–787.
22.
Glaser BM, Campochiaro PA, Davis JL, Sato M: Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol 1985;103:1870–1875.
23.
Gass JDM, Margo CE, Levy M: Progressive subretinal fibrosis and blindness in patients with multifocal granuloumatous chorioretinitis. Am J Ophthalmol 1996;122:76–85.
© 2001 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.